Estimation of the average causal effect among subgroups defined by post-treatment variables

Clinical Trials

Volumn 3, Issue 1, 2006, Pages 1-9

  Matsuyama, Yutaka ^a   Morita, Satoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IRINOTECAN; VINDESINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL TRIAL; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; STATISTICAL MODEL; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CAUSALITY; CLINICAL TRIALS; CONFIDENCE INTERVALS; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS;

EID: 33644600498     PISSN: 17407745     EISSN: None     Source Type: Journal    
DOI: 10.1191/1740774506cn135oa     Document Type: Article

References (23)

1. Rosenbaum PR. The consequences of adjustment for a concomitant variable that has been affected by the treatment. J R Stat Soc Series A - General 1984; 147: 656-66.
2. Robins JM, Greenland S. Identifiability and exchangeability of direct and indirect effects. Epidemiology 1992; 3: 143-55.
3. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics 2002; 58: 21-29.
4. Rubin DB. More powerful randomization-based p-values in double-blind trials with non-compliance. Stat Med 1998; 17: 371-85.
5. Rubin DB. Comment on "Causal inference without counterfactuals" , by A. P. Dawid. J Am Stat Assoc 2000; 95: 435-37.
6. Gilbert PB, Bosch RJ, Hudgens MG. Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials. Biometrics 2003; 59: 531-41.
7. Zhang JL, Rubin DB. Estimation of causal effects via principal stratification when some outcomes are truncated by "death". J Educ Behave Stat 2003; 28: 353-68.
8. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables (with discussion). J Am Stat Assoc 1996; 91: 444-72.
9. Rubin DB. Bayesian inference for causal effects: the role of randomization. Annals Stat 1978; 6: 34-58.
10. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 1974; 66: 688-701.
11. Holland PW. Statistics and causal inference (with discussion). J Am Stat Assoc 1986; 81: 945-70.
12. Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In Proceedings of the Fifth Berkley Symposium in Mathematical Statistics and Probability. University of California Press, 1976: 221-33.
13. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
14. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In Halloran ME, Berry D eds. Statistical models in epidemiology: the environment and clinical trials. Springer-Verlag, 1999: 95-134.
15. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-60.
16. Robins JM, Rotnitzky A, Zhao LP. Estimation of regression coefficients when some regressors are not always observed. J Am Stat Assoc 1994; 89: 846-66.
17. Rubin DB, Thomas N. Affinely invariant matching methods with ellipsoidal distributions. Annals Stat 1992; 20: 1079-93.
18. Rubin DB, Thomas N. Characterizing the effect of matching using linear propensity score methods with normal distributions. Biometrika 1992; 79: 797-809.
19. Rubin DB, Thomas N. Matching using estimated propensity scores: Relating theory to practice. Biometrics 1996; 52: 249-64.
20. Negoro S, Masuda N, Takada Y et al. Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small cell lung cancer. Br J Cancer 2003; 88: 335-41.
21. Robins JM, Rotnitzky A, Zhao LP. Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Stat Assoc 1995; 90: 106-21.
22. Robins JM, Rotnitzky A, Scharfstein DO. Sensitivity analysis for selection bias and unmeasured confounding in missing data and causal inference models. In: Halloran ME, Berry D eds. Statistical models in epidemiology, the environment, and clinical trials. Springer, 1999: 1-94.
23. Balke A, Pearl J. Bounds on treatment effects from studies with imperfect compliance. J Am Stat Assoc 1997; 92: 1171-78.